Exhibit 3.1
Certificate
of Amendment
of
Certificate of Incorporation
of
MYMD PHARMACEUTICALS, INC.
MyMD Pharmaceuticals, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) hereby certifies:
1. | The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of Delaware on October 19, 2023 (the “Certificate of Incorporation”). | |
2. | The Certificate of Incorporation was corrected by the Certificate of Correction thereto, filed with the Secretary of State of Delaware on March 25, 2024. | |
3. | Resolutions were duly adopted by the Board of Directors of the Corporation setting forth this proposed amendment to the Certificate of Incorporation. | |
4. | Article I of the Certificate of Incorporation is hereby amended and restated in its entirety to read as follows: |
“The name of the corporation is TNF Pharmaceuticals, Inc. (hereinafter referred to as the “Corporation”).
5. | The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. | |
6. | The effective date of this Certificate of Amendment to the Certificate of Incorporation shall be July 22, 2024. |
[Signature page follows.]
IN WITNESS WHEREOF, said corporation has caused this Certificate of Amendment to be executed this 22nd day of July, 2024.
MyMD Pharmaceuticals, Inc. | ||
By: | /s/ Mitchell Glass | |
Name: | Mitchell Glass, M.D. | |
Title: | President and Chief Medical Officer |